How the new medicare drug benefit could affect vulnerable populations
about
The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utilityPotential Savings from an Evidence-Based Consumer-Oriented Public Education Campaign on Prescription DrugsHow the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries.Changes in use of lipid-lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage.Income-, education- and gender-related inequalities in out-of-pocket health-care payments for 65+ patients - a systematic review.Living arrangements, chronic diseases, and prescription drug expenditures among Korean elderly: vulnerability to potential medication underuse.Race/ethnicity and nonadherence to prescription medications among seniors: results of a national studyFinancial Consequences of Improved Treatments for Colorectal Cancer.Inequalities in out-of-pocket payments for health care services among elderly Germans--results of a population-based cross-sectional study.Impact of Medicare Part D on Racial and Ethnic Minorities.Housing concerns of vulnerable older Canadians.Beneficial moral hazard and the theory of the second best.Multimorbidity and out-of-pocket expenditure on medicines: a systematic review.
P2860
Q28238484-BC4A2402-A8C6-4176-AAD8-3824B4FAA986Q29393270-D8C828B5-2B59-467B-8BB2-1FA6F340AF4AQ33906706-F7D74C22-2F2E-4252-8EB2-4ACD297E88A3Q34055633-FF8B979C-6083-4C94-B93A-97C679A5AC21Q34078289-89D67C01-0040-498D-8130-AE624570BA61Q34993573-CFA95922-385D-4A50-BEC7-57EA390271A7Q36416879-F5CEF8D2-CA79-4E5C-8E1A-A8E152129EBEQ37336628-98F9E85E-1BA8-4BE2-B3BF-4BD752B710AFQ37485016-3A34B21D-DBBC-4CA2-93B6-15033ABD2372Q39051148-85E6309C-B489-44BA-806A-1374F98CA259Q39847175-539692AA-6D0D-4C85-B386-11B52FC419BBQ49072897-1CBCEB2A-77A0-41E4-B490-AA6CF1E9768DQ52346997-9324E0B9-6B3E-4BD1-B654-0CA8E70C9956
P2860
How the new medicare drug benefit could affect vulnerable populations
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
How the new medicare drug benefit could affect vulnerable populations
@ast
How the new medicare drug benefit could affect vulnerable populations
@en
How the new medicare drug benefit could affect vulnerable populations
@nl
type
label
How the new medicare drug benefit could affect vulnerable populations
@ast
How the new medicare drug benefit could affect vulnerable populations
@en
How the new medicare drug benefit could affect vulnerable populations
@nl
prefLabel
How the new medicare drug benefit could affect vulnerable populations
@ast
How the new medicare drug benefit could affect vulnerable populations
@en
How the new medicare drug benefit could affect vulnerable populations
@nl
P2093
P2860
P356
P1433
P1476
How the new medicare drug benefit could affect vulnerable populations
@en
P2093
Haiden A Huskamp
Jennifer S Haas
Kathryn A Phillips
Walid F Gellad
P2860
P304
P356
10.1377/HLTHAFF.25.1.248
P407
P577
2006-01-01T00:00:00Z